AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $456.4M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 16.12pm 28/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | $1.47 | Day High | $1.48 | Day Low | $1.40 | |||
| Daily Volume | 323689 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | $1.41 | 5739 | 0 | $1.48 | 2022 | |
Directors & Senior Management
| Mr. Andrew Murray Lloyd | Independent Non-Executive Director |
| Mr. Douglas Campbell Walter Ritchie | Independent Non-Executive Chairman |
| Dr. Jennifer Marilyn Purdie | Independent Non-Executive Director |
| Mr. Nathan Quinlin | Chief Financial Officer |
| Mr. Norman Ting | General Manager of Marketing and Sales |
| Mr. Paul Green | Executive General Manager Operations |
| Hon. Paul Lucas | Independent Non-Executive Director |
| Ms. Robin Bates | General Counsel |
| Mr. Rudi Cohrssen | Company Secretary |
| Mr. Simon Wensley | CEO, MD & Director |
| Mr. Troy McMillan | General Manager of People & Culture |
Data source: ADVFN
